Soluble CD14 levels are increased and inversely correlated with the levels of hepatitis B surface antigen in chronic hepatitis B patients

被引:13
作者
Steyaert, S
Vanlandschoot, P
Van Vlierberghe, H
Diepolder, H
Leroux-Roels, G
机构
[1] State Univ Ghent Hosp, Ctr Vaccinol, B-9000 Ghent, Belgium
[2] State Univ Ghent Hosp, Dept Gastroenterol, B-9000 Ghent, Belgium
[3] Univ Hosp Munich, Med Dept 2, Munich, Germany
关键词
sCD14; HBsAg; lipopolysaccharide binding protein; C-reactive protein; chronic hepatitis B;
D O I
10.1002/jmv.10469
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Because it was observed recently that yeast-derived recombinant HBsAg interacts in a lipopolysaccharicle binding protein-dependent manner with CD14 expressed on human monocytes, we investigated whether HBsAg influences the serum levels of sCD14, lipopolysaccharide binding protein and C-reactive protein in hepatitis B patients. Samples from acute and chronic hepatitis B and chronic hepatitis C patients were tested. All analytes were measured using commercial assays. HBsAg was quantified using an NIBSC titrated standard. sCD14 levels were higher in chronic hepatitis B and C patients than in healthy controls (P=0.0006 and P<0.0001, respectively). In chronic hepatitis B patients an inverse correlation was found between sCD14 and HBsAg (P=0.0309). Lipopolysaccharide binding protein and C-reactive protein levels were higher in acute hepatitis B patients than in control subjects (P=0.0217 and P=0.0034, respectively). In chronic hepatitis B and C, sCD14 and C-reactive protein levels were higher in cirrhotic than in non-cirrhotic patients (P=0.0072 and P=0.0223, respectively). (C) 2003Wiley-Liss, Inc.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 18 条
[1]  
Antal-Szalmás P, 2000, EUR J CLIN INVEST, V30, P167
[2]   Tlr4: central component of the sole mammalian LPS sensor [J].
Beutler, B .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :20-26
[3]   RISKS OF CHRONICITY FOLLOWING ACUTE HEPATITIS-B VIRUS-INFECTION - A REVIEW [J].
HYAMS, KC .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :992-1000
[4]   Soluble(s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-α [J].
Jirillo, E ;
Amati, L ;
Caradonna, L ;
Greco, B ;
Cozzolongo, R ;
Cuppone, R ;
Piazzolla, G ;
Caccavo, D ;
Antonaci, S ;
Manghisi, OG .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1998, 20 (01) :1-14
[5]   Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting [J].
Kaser, A ;
Ludwiczek, O ;
Waldenberger, P ;
Jaschke, W ;
Vogel, W ;
Tilg, H .
LIVER, 2002, 22 (05) :380-387
[6]   Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection:: Correlation to disease progression and clinical events [J].
Lien, E ;
Aukrust, P ;
Sundan, A ;
Müller, F ;
Froland, SS ;
Espevik, T .
BLOOD, 1998, 92 (06) :2084-2092
[7]   Update on diagnosis, management, and prevention of hepatitis B virus infection [J].
Mahoney, FJ .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (02) :351-+
[8]   INCREASED IN-VITRO PRODUCTION AND SERUM LEVELS OF THE SOLUBLE LIPOPOLYSACCHARIDE RECEPTOR SCD14 IN LIVER-DISEASE [J].
OESTERREICHER, C ;
PFEFFEL, F ;
PETERMANN, D ;
MULLER, C .
JOURNAL OF HEPATOLOGY, 1995, 23 (04) :396-402
[9]  
Roberts WL, 2000, CLIN CHEM, V46, P461
[10]   MedCalc: A new computer program for medical statistics [J].
Schoonjans, F ;
Zalata, A ;
Depuydt, CE ;
Comhaire, FH .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1995, 48 (03) :257-262